Intermediate Monocytes but Not TIE2-Expressing Monocytes Are a Sensitive Diagnostic Indicator for Colorectal Cancer

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Schauer, Dominic ^a   Starlinger, Patrick ^a   Reiter, Christian ^a   Jahn, Nikolaus ^a   Zajc, Philipp ^a   Buchberger, Elisabeth ^a   Bachleitner Hofmann, Thomas ^a   Bergmann, Michael ^a   Stift, Anton ^a   Gruenberger, Thomas ^a   Brostjan, Christine ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN RECEPTOR; CD14 ANTIGEN; CD16 ANTIGEN; CYTOKINE;

ADULT; AGED; ARTICLE; CELL SUBPOPULATION; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; INTERMEDIATE MONOCYTE; MAJOR CLINICAL STUDY; MALE; METASTASIS; MONOCYTE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY;

ANTIGENS, CD14; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; CYTOKINES; FLOW CYTOMETRY; HUMANS; MONOCYTES; PREDICTIVE VALUE OF TESTS; RECEPTOR, TIE-2; RECEPTORS, IGG; REGRESSION ANALYSIS; SENSITIVITY AND SPECIFICITY;

EID: 84866049272     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044450     Document Type: Article

References (40)

1. Yona S, Jung S, (2010) Monocytes: subsets, origins, fates and functions. Curr Opin Hematol 17: 53-59.
2. Ziegler-Heitbrock HW, Passlick B, Flieger D, (1988) The monoclonal antimonocyte antibody My4 stains B lymphocytes and two distinct monocyte subsets in human peripheral blood. Hybridoma 7: 521-527.
3. Passlick B, Flieger D, Ziegler-Heitbrock HW, (1989) Identification and characterization of a novel monocyte subpopulation in human peripheral blood. Blood 74: 2527-2534.
4. Ancuta P, Rao R, Moses A, Mehle A, Shaw SK, et al. (2003) Fractalkine preferentially mediates arrest and migration of CD16+ monocytes. J Exp Med 197: 1701-1707.
5. Ziegler-Heitbrock L, Ancuta P, Crowe S, Dalod M, Grau V, et al. (2010) Nomenclature of monocytes and dendritic cells in blood. Blood 116: e74-80.
6. Zawada AM, Rogacev KS, Rotter B, Winter P, Marell RR, et al. (2011) SuperSAGE evidence for CD14++CD16+ monocytes as a third monocyte subset. Blood 118: e50-61.
7. Wong KL, Tai JJ, Wong WC, Han H, Sem X, et al. (2011) Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets. Blood 118: e16-31.
8. Clarkson SB, Ory PA, (1988) CD16. Developmentally regulated IgG Fc receptors on cultured human monocytes. J Exp Med 167: 408-420.
9. Ziegler-Heitbrock HW, Fingerle G, Strobel M, Schraut W, Stelter F, et al. (1993) The novel subset of CD14+/CD16+ blood monocytes exhibits features of tissue macrophages. Eur J Immunol 23: 2053-2058.
10. Feng AL, Zhu JK, Sun JT, Yang MX, Neckenig MR, et al. (2011) CD16+ monocytes in breast cancer patients: expanded by monocyte chemoattractant protein-1 and may be useful for early diagnosis. Clin Exp Immunol 164: 57-65.
11. Munn DH, Cheung NK, (1989) Antibody-dependent antitumor cytotoxicity by human monocytes cultured with recombinant macrophage colony-stimulating factor. Induction of efficient antibody-mediated antitumor cytotoxicity not detected by isotope release assays. J Exp Med 170: 511-526.
12. Wong HL, Welch GR, Brandes ME, Wahl SM, (1991) IL-4 antagonizes induction of Fc gamma RIII (CD16) expression by transforming growth factor-beta on human monocytes. J Immunol 147: 1843-1848.
13. Cros J, Cagnard N, Woollard K, Patey N, Zhang SY, et al. (2010) Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors. Immunity 33: 375-386.
14. Skrzeczynska-Moncznik J, Bzowska M, Loseke S, Grage-Griebenow E, Zembala M, et al. (2008) Peripheral blood CD14high CD16+ monocytes are main producers of IL-10. Scand J Immunol 67: 152-159.
15. Murdoch C, Tazzyman S, Webster S, Lewis CE, (2007) Expression of Tie-2 by human monocytes and their responses to angiopoietin-2. J Immunol 178: 7405-7411.
16. De Palma M, Venneri MA, Galli R, Sergi Sergi L, Politi LS, et al. (2005) Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell 8: 211-226.
17. Venneri MA, De Palma M, Ponzoni M, Pucci F, Scielzo C, et al. (2007) Identification of proangiogenic TIE2-expressing monocytes (TEMs) in human peripheral blood and cancer. Blood 109: 5276-5285.
18. Coffelt SB, Tal AO, Scholz A, De Palma M, Patel S, et al. (2010) Angiopoietin-2 regulates gene expression in TIE2-expressing monocytes and augments their inherent proangiogenic functions. Cancer Res 70: 5270-5280.
19. Marron MB, Singh H, Tahir TA, Kavumkal J, Kim HZ, et al. (2007) Regulated proteolytic processing of Tie1 modulates ligand responsiveness of the receptor-tyrosine kinase Tie2. J Biol Chem 282: 30509-30517.
20. Fingerle G, Pforte A, Passlick B, Blumenstein M, Strobel M, et al. (1993) The novel subset of CD14+/CD16+ blood monocytes is expanded in sepsis patients. Blood 82: 3170-3176.
21. Zhang JY, Zou ZS, Huang A, Zhang Z, Fu JL, et al. (2011) Hyper-activated pro-inflammatory CD16 monocytes correlate with the severity of liver injury and fibrosis in patients with chronic hepatitis B. PLoS One. 6: e17484.
22. Schlitt A, Heine GH, Blankenberg S, Espinola-Klein C, Dopheide JF, et al. (2004) CD14+CD16+ monocytes in coronary artery disease and their relationship to serum TNF-alpha levels. Thromb Haemost 92: 419-424.
23. Saleh MN, Goldman SJ, LoBuglio AF, Beall AC, Sabio H, et al. (1995) CD16+ monocytes in patients with cancer: spontaneous elevation and pharmacologic induction by recombinant human macrophage colony-stimulating factor. Blood 85: 2910-2917.
24. Moniuszko M, Bodzenta-Lukaszyk A, Kowal K, Lenczewska D, Dabrowska M, (2009) Enhanced frequencies of CD14++CD16+, but not CD14+CD16+, peripheral blood monocytes in severe asthmatic patients. Clin Immunol 130: 338-346.
25. Heine GH, Ulrich C, Seibert E, Seiler S, Marell J, et al. (2008) CD14(++)CD16+ monocytes but not total monocyte numbers predict cardiovascular events in dialysis patients. Kidney Int 73: 622-629.
26. Starlinger P, Alidzanovic L, Schauer D, Brugger P, Sommerfeldt S, et al. (2011) Platelet-stored angiogenesis factors: Clinical monitoring is prone to artifacts. Dis Markers 31: 55-65.
27. Schaaf B, Luitjens K, Goldmann T, van Bremen T, Sayk F, et al. (2009) Mortality in human sepsis is associated with downregulation of Toll-like receptor 2 and CD14 expression on blood monocytes. Diagn Pathol 4: 12.
28. Schmid I, Baldwin GC, Jacobs EL, Isacescu V, Neagos N, et al. (1995) Alterations in phenotype and cell-surface antigen expression levels of human monocytes: differential response to in vivo administration of rhM-CSF or rhGM-CSF. Cytometry 22: 103-110.
29. Subimerb C, Pinlaor S, Lulitanond V, Khuntikeo N, Okada S, et al. (2010) Circulating CD14(+) CD16(+) monocyte levels predict tissue invasive character of cholangiocarcinoma. Clin Exp Immunol 161: 471-479.
30. Ziegler-Heitbrock L, (2007) The CD14+ CD16+ blood monocytes: their role in infection and inflammation. J Leukoc Biol 81: 584-592.
31. Herra CM, Keane CT, Whelan A, (1996) Increased expression of Fc gamma receptors on neutrophils and monocytes may reflect ongoing bacterial infection. J Med Microbiol 44: 135-140.
32. Skrzeczynska J, Kobylarz K, Hartwich Z, Zembala M, Pryjma J, (2002) CD14+CD16+ monocytes in the course of sepsis in neonates and small children: monitoring and functional studies. Scand J Immunol 55: 629-638.
33. Tsujimoto H, Ono S, Hiraki S, Majima T, Kawarabayashi N, et al. (2004) Hemoperfusion with polymyxin B-immobilized fibers reduced the number of CD16+ CD14+ monocytes in patients with septic shock. J Endotoxin Res 10: 229-237.
34. Heimbeck I, Hofer TP, Eder C, Wright AK, Frankenberger M, et al. (2010) Standardized single-platform assay for human monocyte subpopulations: Lower CD14+CD16++ monocytes in females. Cytometry A 77: 823-830.
35. Hristov M, Schmitz S, Schuhmann C, Leyendecker T, von Hundelshausen P, et al. (2009) An optimized flow cytometry protocol for analysis of angiogenic monocytes and endothelial progenitor cells in peripheral blood. Cytometry A 75: 848-853.
36. Nijziel MR, van Oerle R, van Pampus EC, de Vet HC, Hillen HF, et al. (2000) Increased D-dimer levels correlate with binding of activated protein C, but not tissue factor expression, on peripheral blood monocytes in cancer patients. Am J Hematol 64: 282-286.
37. Kruger M, Coorevits L, De Wit TP, Casteels-Van Daele M, Van De Winkel JG, et al. (1996) Granulocyte-macrophage colony-stimulating factor antagonizes the transforming growth factor-beta-induced expression of Fc gamma RIII (CD16) on human monocytes. Immunology 87: 162-167.
38. Szaflarska A, Baj-Krzyworzeka M, Siedlar M, Weglarczyk K, Ruggiero I, et al. (2004) Antitumor response of CD14+/CD16+ monocyte subpopulation. Exp Hematol 32: 748-755.
39. De Palma M, Murdoch C, Venneri MA, Naldini L, Lewis CE, (2007) Tie2-expressing monocytes: regulation of tumor angiogenesis and therapeutic implications. Trends Immunol 28: 519-524.
40. Goede V, Coutelle O, Shimabukuro-Vornhagen A, Holtick U, Neuneier J, et al. (2012) Analysis of Tie2-expressing monocytes (TEM) in patients with colorectal cancer. Cancer Invest 30: 225-230.